News & Updates
Filter by Specialty:
COVID-19 does mess with the brain even years after infection
A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.
COVID-19 does mess with the brain even years after infection
06 Jun 2024
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
Patients with postacute COVID-19 syndrome (PACS) may benefit from faecal microbiota transplantation (FMT) treatment, which helps reduce anxiety and improve sleep quality, suggests a study.
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
05 Jun 2024
Novel agent plus ritonavir shows favourable signals for mild-to-moderate COVID-19
A combination regimen comprising the novel agent GST-HG171 (also known as atilotrelvir) and ritonavir improves clinical symptom recovery and viral clearance in low-risk vaccinated adults with mild-to-moderate COVID-19, findings from a pivotal phase II/III study have shown.
Novel agent plus ritonavir shows favourable signals for mild-to-moderate COVID-19
05 Jun 2024
Mum’s infection during pregnancy may raise newborn’s risk of IBD
Exposure to any infection during early pregnancy or to a gastrointestinal infection during late pregnancy contributes to the increased likelihood of inflammatory bowel disease (IBD) development, especially Crohn’s disease, in the offspring, according to a study.
Mum’s infection during pregnancy may raise newborn’s risk of IBD
23 May 2024
Which regimen is best for antibiotic-resistant H pylori?
In regions where there is high antibiotic resistance of Helicobacter pylori (H pylori), the best options in treatment-naïve patients include the 3-in-1 single capsule, bismuth quadruple therapy, and concomitant regimen with tinidazole, suggests a study. In non-naïve patients, the 3-in-1 single capsule and the triple therapy with levofloxacin offers adequate eradication.